Assay Development Phase (~3-6 months)

  • User submits assay plan to OTRADI
  • User develops primary screen, with secondary assay in place
  • OTRADI works with User to make assay amenable to automation, including miniaturization to 96-well and/or 384-well format
  • OTRADI & User create written automation protocol
  • OTRADI & User demonstrate assay robustness and suitability for the HTS or HCA format to
  • determine when assay metrics are suitable for screening
  • OTRADI creates screening schedule with projected start date & timeline

Scaling Assays & Performing Screens (~2-3 months)

  • OTRADI coordinates reagents, consumables & compound libraries
  • OTRADI performs pilot screen of up to 2000 compounds in one batch
  • OTRADI & User analyze pilot screen data. If acceptable, continue timeline to screen additional larger compound libraries

Data-Processing, Cherry Picking & Hit Confirmation (~2-3 months)

  • OTRADI creates Assay Report summarizing results of compound library screens & distributes to User
  • OTRADI manages QC metrics and hits
  • User & OTRADI choose compounds for cherry picking and hit confirmation

Potency & Follow-On Experiments (~2-3 months)

  • After hit confirmation, OTRADI & User may schedule dose-response experiments to measure potency of hit
  • OTRADI & User can discuss, plan and schedule follow-on experiments (secondary assays, cytotoxicity, cellular analysis (HCA), PK, etc.)

Working with OTRADI

Learn more about how you can partner with OTRADI and leverage our world-class scientific equipment and expertise. More

Resources

We use state-of-the-art laboratory equipment to facilitate research and development. More